Candidiasis: Clinical Trials

6 trials for Candidiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Unknown 6
Phase 21Unknown 1

Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis
SHR8008, Fluconazole - Recurrent Vulvovaginal Candidiasis
Phase 3UnknownJiangsu HengRui Medicine Co., Ltd.1962021-09-142021-10-12
A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis
Phase 2 / Phase 3UnknownProFem GmbH4322019-10-012022-09-22
Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis
caspofungin antifungal therapy, placebo - ICU Yeast Intra-abdominal Infection
Phase 3UnknownCentre Hospitalier Universitaire, Amiens4482019-01-012024-07-10
Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis
Ketoconazole, Terconazole - Vaginal Candidiasis
Phase 3UnknownAssiut University692018-04-012018-03-22
Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia
Interferon-gamma, Recombinant - Candidemia
Phase 3UnknownRadboud University Medical Center202011-01-012012-02-14
Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis
Clindamycin 100mg and Ketoconazole 400mg, Tetracycline 100mg and Amphotericin B 50mg - Candidiasis, Bacterial Vaginosis
Phase 3UnknownZodiac Produtos Farmaceuticos S.A.1602009-09-012009-04-28

Narrower conditions

Candidiasis, Vulvovaginal (3)  ·  Candidemia (1)  ·  Invasive Fungal Infections (1)  ·  Vaginosis, Bacterial (1)  ·  Vulvovaginitis (1)

Broader conditions

Bacterial Infections and Mycoses (6)  ·  Infections (6)  ·  Mycoses (6)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Urogenital Diseases (4)  ·  Vaginal Diseases (4)  ·  Vaginitis (4)  ·  Vulvar Diseases (3)  ·  Vulvitis (3)  ·  Vulvovaginitis (2)  ·  Bacterial Infections (1)

Interventions

Fluconazole (2)  ·  Ketoconazole (2)  ·  Amphotericin B (1)  ·  Clindamycin (1)  ·  Interferon-gamma (1)  ·  Tetracycline (1)  ·  terconazole (1)

Sponsors

Assiut University (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)  ·  ProFem GmbH (1)  ·  Radboud University Medical Center (1)  ·  Zodiac Produtos Farmaceuticos S.A. (1)

Countries

Austria (1)  ·  Brazil (1)  ·  China (1)  ·  France (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Slovakia (1)

Top investigators

Corine Delsing, MD (1)  ·  Herbert Kiss, Prof. (1)  ·  Mihai Netea, MD PhD (1)  ·  Rogerio Bonassi Machado, MD (1)

Results publications

PMID 24669841, PMID 41845293

NIH funding

2009 (1)